Cite

HARVARD Citation

    Martini, G. et al. (2022). Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab. International journal of cancer. 151 (3), pp. 473-480. [Online]. 
  
Back to record